Rockwell Medical price target lowered to $3 from $7 at H.C. Wainwright

H.C. Wainwright analyst Raghuram Selvaraju lowered the firm’s price target on Rockwell Medical (RMTI) to $3 from $7 and keeps a Buy rating on the shares. The firm cites the impact of the loss of business from the company’s largest customer on the revenue growth trajectory in the near- and medium-term for the target cut.